When an EMVS alert traces back to a CMO, investigation speed depends on the coordination model you built before the alert arrived. Here's how to design it.
Digital Factory Maturity in Pharma: How to Build a Roadmap That Actually Works
Digital Factory maturity has moved well past the stage of being a strategic aspiration. In 2026, it is an operational imperative, the backbone of a resilient pharma supply chain, one that determines whether your site can release products faster, sustain compliance under regulatory scrutiny, and scale without the kind of...
Automation Before Autonomous with RPA
The pharma supply chain is not a forgiving environment for shortcuts. The processes are complex, the regulatory exposure is real, and the downstream impact of poor data or unclear ownership is significant. Autonomous actions, at any meaningful scale, require you to have already solved for that complexity, not planned to...
How MAHs Reduce EU FMD Alerts (Root Causes, Prevention, and Continuous Improvement)
Reducing alerts is often framed as an execution problem, how quickly can teams investigate and close them? But in practice, the real issue is different. It is not the volume of alerts, but the quality of those alerts.
Smart Pharma Factories: Linking Digital Manufacturing (MES) to the Supply Chain in Real Time
The era of the "smart pharma factory" is finally bridging this divide. By integrating digital manufacturing systems, specifically the Manufacturing Execution System (MES), with the broader pharma supply chain, companies are unlocking live visibility and unprecedented responsiveness.
